| Dr Sassia L Brave, MD | |
|
86 W Underwood St, Orlando, FL 32806-1110 | |
| (321) 843-5270 | |
| (321) 843-5177 |
| Full Name | Dr Sassia L Brave |
|---|---|
| Gender | Female |
| Speciality | Critical Care (intensivists) |
| Experience | 22 Years |
| Location | 86 W Underwood St, Orlando, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508002916 | NPI | - | NPPES |
| 740589 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Orlando Health | Orlando, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orlando Health Medical Group Inc | 9537059084 | 1417 |
News Archive
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
Lung cancer is the leading cause of cancer-associated deaths in the United States. Non-small cell lung cancer (NSCLC), a group of lung cancers named for the kinds of cells found in the cancer, constitutes more than 80% of all lung cancer cases.
Having a father who is relatively young or old may increase a person's risk of developing bipolar disorder, a study suggests.
Keratin 17 (K17), a protein that promotes cancer, may prove to be a key target gene in the battle against pancreatic cancer.
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
› Verified 2 days ago
| Entity Name | Orlando Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669429577 PECOS PAC ID: 9537059084 Enrollment ID: O20040318000044 |
News Archive
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
Lung cancer is the leading cause of cancer-associated deaths in the United States. Non-small cell lung cancer (NSCLC), a group of lung cancers named for the kinds of cells found in the cancer, constitutes more than 80% of all lung cancer cases.
Having a father who is relatively young or old may increase a person's risk of developing bipolar disorder, a study suggests.
Keratin 17 (K17), a protein that promotes cancer, may prove to be a key target gene in the battle against pancreatic cancer.
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sassia L Brave, MD 86 W Underwood St, Orlando, FL 32806-1110 Ph: (321) 843-5270 | Dr Sassia L Brave, MD 86 W Underwood St, Orlando, FL 32806-1110 Ph: (321) 843-5270 |
News Archive
A study led by UCLA researchers found that adding ribociclib, a targeted therapy drug, to standard hormone therapy has been shown to significantly improve overall survival in postmenopausal women with advanced hormone-receptor positive/HER2- breast cancer, one of the most common forms of the disease.
Lung cancer is the leading cause of cancer-associated deaths in the United States. Non-small cell lung cancer (NSCLC), a group of lung cancers named for the kinds of cells found in the cancer, constitutes more than 80% of all lung cancer cases.
Having a father who is relatively young or old may increase a person's risk of developing bipolar disorder, a study suggests.
Keratin 17 (K17), a protein that promotes cancer, may prove to be a key target gene in the battle against pancreatic cancer.
Boehringer Ingelheim today announced that interim data from its Phase II hepatitis C (HCV) clinical collaboration with Presidio Pharmaceuticals have been accepted for presentation as a late breaker poster at the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), taking place 1-5 November in Washington, D.C. (1) The poster presentation will be on Monday 4 November.
› Verified 2 days ago
Vamsi Kiran Kodumuri, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 258 S Chickasaw Trl Ste 203, Orlando, FL 32825 Phone: 407-303-6588 | |
Francoeur Cadet, D.O Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 232 N Orange Blossom Trl, Orlando, FL 32805 Phone: 407-428-5751 Fax: 407-447-7245 | |
Andrija Vidic, D.O Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 2415 N Orange Ave Ste 700, Orlando, FL 32804 Phone: 407-303-2474 Fax: 407-303-0680 | |
Azin Azarfar, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 3400 Quadrangle Blvd, Orlando, FL 32817 Phone: 407-266-3627 Fax: 407-266-4911 | |
Zain Zamir, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2501 N Orange Ave Ste 235, Orlando, FL 32804 Phone: 407-303-7169 | |
Dr. Arsenio R Rodriguez, MD Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 1745 N Mills Avenue, Orlando, FL 32803 Phone: 407-841-7151 Fax: 407-648-2259 | |
Dr. Maria R Flores, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 W Gore St, Suite 100, Orlando, FL 32806 Phone: 407-426-8484 Fax: 404-426-8575 |